9th Annual Neurotech Investing and Partnering Conference

9th Annual Neurotech Investing and Partnering Conference

23-04-2014 - 24-04-2014 Ritz-Carlton, Boston, MA

Join neurotech CEOs, investors, and partners from around the world at the 9th Annual Neurotech Investing and Partnering Conference.

Join neurotech CEOs, investors, and partners from around the world at the 9th Annual Neurotech Investing and Partnering Conference. The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.

This market defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.

Hear about next generation treatments for Alzheimer's, addiction, anxiety, depression, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more.

Conference Highlights

At The Neurotech Conference you'll get a first-hand glimpse of What's in the Pipeline:

  • Find out about new product licensing and partnering opportunities

  • Learn what venture and strategic investors are looking for

  • Discover emerging technologies and companies

 

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Merck

merck-small.jpg

US pharma giant Merck & Co (NYSE: MRK) is known as Merck in the USA and Canada; everywhere else, it is known as MSD.

Back to top